FDA Pharmaceutical Science/PAT Subcommittee fall meeting
Executive Summary
FDA's Pharmaceutical Science/Process Analytical Technologies Subcommittee's final meeting in September or October will discuss computer validation for manufacturing, rapid microbial testing and simulated PAT applications, FDA tells the subcommittee's June 12 meeting. The agency tentatively plans to incorporate principles related to rapid microbial testing into its first PAT guidance (1"The Pink Sheet" May 20, p. 8)...
You may also be interested in...
Microbial Rapid Testing Principles Likely To Be Added To PAT Guidance
FDA will likely incorporate principles related to rapid microbial testing in its upcoming guidance on process analytical technologies
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.